BRAF and melanoma: Of the Raf kinases, B-Raf has the highest intrinsic kinase activity and is mutated in 50–70% of malignant melanomas, 40% of thyroid carcinomas, 30% of ovarian tumours, and nearly 100% of hairy cell leukaemias (Turski et al, 2016).